| Prev Close | 29.95 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 15.25 / 39.20 |
| Avg Volume | 466.30K |
| Exchange | NASDAQ |
| Shares Outstanding | 32.36M |
| Market Cap | 995.07M |
| EPS | 1.90 |
| P/E Ratio | 20.23 |
| Div & Yield | N.A. (N.A) |
In recent trading, shares of BioTelemetry Inc have crossed above the average analyst 12-month target price of $33.00, changing hands for $34.40/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
Deal Solidifies BioTelemetry's Leadership Position in Remote Cardiac Monitoring
In recent trading, shares of BioTelemetry Inc have crossed above the average analyst 12-month target price of $28.67, changing hands for $29.65/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
In recent trading, shares of BioTelemetry Inc have crossed above the average analyst 12-month target price of $28.67, changing hands for $28.75/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in BioTelemetry Inc , where a total volume of 2,390 contracts has been traded thus far today, a contract volume which is representative of approximately 239,000 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 45.3% of BEAT's average daily trading volume over the past month, of 528,120 shares.
Company Reports Record Quarterly Revenue and Patient Volume
LifeWatch Board of Directors Supports BioTelemetry Tender Offer
Investors eyeing a purchase of BioTelemetry Inc shares, but cautious about paying the going market price of $30.32/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $27 strike, which has a bid at the time of this writing of $2.10.
Strengthens Remote Patient Monitoring Platform
BEAT is the ticker symbol for this health care name, which we think Sonny and Cher would love.
Company Reports Record Results
In recent trading, shares of BioTelemetry Inc have crossed above the average analyst 12-month target price of $25.00, changing hands for $25.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.
Award Recognizes Businesses that Deployed Successful IoT Solutions
Extends reach into rapidly expanding digital population health management market
Investors eyeing a purchase of BioTelemetry Inc stock, but cautious about paying the going market price of $16.82/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the May 2017 put at the $15 strike, which has a bid at the time of this writing of $1.30.
